https://www.selleckchem.com/pr....oducts/cbl0137-cbl-0
redictors for symptomatically suspected COVID-19 cases. There was no association between incidence of COVID-19 and use of reflux medications, including famotidine at doses used orally to manage reflux and high dose PPIs. Reflux medications did not protect against or increase the risk of COVID-19. There was no association between incidence of COVID-19 and use of reflux medications, including famotidine at doses used orally to manage reflux and high dose PPIs. Reflux medications did not protect against or increase the risk of COV
Like
Comment
Share
